FBIO and FBIOP Related Headlines
Go Back- Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
- Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
- Fortress Biotech unit to sell rare disease voucher for $205 million
- UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
FBIO and FBIOP Related Press Releases
Go Back- Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
- Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
- UPDATE: Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
